Effect of perioperative blood transfusion on recurrence and survival in 232 primary high-grade extremity sarcoma patients
Authors:
- 1 May 1994
- journal article
- research article
- Published by Springer Nature in Annals of Surgical Oncology
- Vol. 1 (3) , 189-197
Abstract
Background: Allogeneic blood transfusion (BT) has been implicated as an unfavorable factor influencing cancer recurrence and overall survival. Methods: To investigate this, 232 consecutive localized, high-grade extremity soft tissue sarcoma (STS) patients admitted between January 1, 1983, and December 31, 1989, were analyzed from our prospective database by univariable and Cox multivariable statistical methods. Results: Twenty-eight patients developed a local recurrence (LR). Factors found significantly unfavorable for the rate of developing an LR by uni- and multivariable tests were age >60 years and positive microscopic margin. Eighty-nine patients developed a distant metastasis (DM) and 72 patients died of their tumor. Median follow-up of survivors was 48 months. Unfavorable factors for DM and tumor mortality (TM) by univariable analysis included large size, deep tumor (that involved or was below the superficial fascia), positive microscopic margin, invasion of a vital structure, operative blood loss, duration of operation, and perioperative BT (whole blood or packed cells -24 to +48 h of curative operation). Multivariable analysis found large size, deep tumor, and positive margin significant independent unfavorable factors for DM and TM. The effect of BT was not a significant independent prognosticator for LR, DM, or TM by multivariable analysis (p=0.26, 0.56, 0.08, respectively), The only factor that was found to be significant in a multivariable analysis of factors contributing to postmetastasis survival was time <6 months until metastasis (p=0.008). BT had no significant impact on postmetastasis survival (p=0.42). There was a significant association between BT and deep, large tumors. As the size of deep tumors increased from <5, ≥5<10, ≥10<15, or≥15 cm, the amount transfused was 15, 16, 49, and 68% (p<0.00001). Also, BT was significantly (p<0.005) associated with low hematocrit at initial diagnosis, blood loss during surgery, and the length of the surgical procedure. Conclusions: These data emphasize the importance of size, depth, and margin on distant recurrence and death for localized high-grade extremity STS. In the absence of a randomized trial, the impact of allogeneic blood transfusion would appear to be due to its strong association with large size and deep tumor invasion. This study also highlights the importance of a multivariable analysis and long-term follow-up to better define this controversial question.Keywords
This publication has 28 references indexed in Scilit:
- A prospective randomized trial of adjuvant chemotherapy with bolus versus continuous infusion of doxorubicin in patients with high-grade extremity soft tissue sarcoma and an analysis of prognostic factorsCancer, 1991
- The Influence of Intraoperative Hypotension and Perioperative Blood Transfusion on Disease-free Survival in Patients with Complete Resection of Golorectal Liver MetastasesAnnals of Surgery, 1991
- The Effect of Anesthetic Agents on the Human Immune ResponseAnesthesiology, 1990
- Adverse affect of blood transfusions on survival of patients with gastric cancerTransfusion, 1987
- Perioperative blood transfusion and cancer prognosis. Different effects of blood transfusion on prognosis of colon and breast cancer patientsCancer, 1987
- The influence of surgical operations on components of the human immune systemBritish Journal of Surgery, 1985
- The Treatment of Soft-tissue Sarcomas of the ExtremitiesAnnals of Surgery, 1982
- EFFECT OF BLOOD TRANSFUSIONS ON COLONIC MALIGNANCY RECURRENCE RATEThe Lancet, 1982
- RED BLOOD CELLS FOR CANCER PATIENTSThe Lancet, 1981
- Nonparametric Estimation from Incomplete ObservationsJournal of the American Statistical Association, 1958